SCHEMBL14726730

SCHEMBL14726730

CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C=C(C)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.71
ESR1 P03372 1/20 0.71
ESR2 Q92731 1/20 0.71
SRD5A2 P31213 7/20 0.65
SRD5A1 P18405 4/20 0.65
LMNA P02545 4/20 0.59
SERPINA6 P08185 3/20 0.59
SHBG P04278 2/20 0.59
G6PD P11413 1/20 0.59
CYP3A4 P08684 3/20 0.56
CYP2C9 P11712 2/20 0.56
TSHR P16473 2/20 0.56
HIF1A Q16665 2/20 0.56
ALDH1A1 P00352 2/20 0.56
MAPT P10636 2/20 0.56
MAPK1 P28482 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
CYP2C19 P33261 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13378032 1.00 AR (0.71) ARESR1ESR2SRD5A2SRD5A1
SCHEMBL11515941 0.89 SRD5A2 (0.65) ARESR1ESR2SRD5A2SRD5A1
SCHEMBL13265741 0.86 SRD5A2 (0.62) ARESR1ESR2SRD5A2SRD5A1
SCHEMBL370474 0.86 SRD5A2 (0.62) ARESR1ESR2SRD5A2SRD5A1
SCHEMBL7622300 0.86 SRD5A2 (0.62) ARESR1ESR2SRD5A2SRD5A1
SCHEMBL30332128 0.85 SRD5A2 (0.61) ARESR1ESR2SRD5A2SRD5A1
SCHEMBL14729818 0.85 SRD5A2 (0.61) ARESR1ESR2SRD5A2SRD5A1
SCHEMBL5166591 0.83 ESR1 (1.00) ARESR1ESR2LMNASERPINA6
SCHEMBL5166597 0.83 ESR1 (1.00) ARESR1ESR2LMNASERPINA6
SCHEMBL14430121 0.83 ESR1 (1.00) ARESR1ESR2LMNASERPINA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809567-B2 Method for producing silylenol ethers KYOTO UNIVERSITY (JP) 2014-08-19 US disclosed
US-20130053567-A1 METHOD FOR PRODUCING SILYLENOL ETHERS KYOTO UNIVERSITY (JP) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053567-A1 METHOD FOR PRODUCING SILYLENOL ETHERS AKR7A2, MSMO1, CYP2E1 AR 527/4885ESR1 1633/4885ESR2 1342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.